StockData
Sangamo Therapeutics, Inc logo

Sangamo Therapeutics, Inc (SGMOQ) stock

SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 4/30
$0.10−0.01 (-8.17%)

Close on Oct 19, 2026Market cap $39.43MP/E –Yield –

Sangamo Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Sangamo Therapeutics's price to sales ratio was 0.9× on Oct 19, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 0.4× to 25.6×, with a median of 3.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.9×−2.2
2025Dec 31, 20253.2×−0.6
2024Dec 31, 20243.8×+3.3
2023Dec 29, 20230.5×−3.7
2022Dec 30, 20224.2×−5.7
2021Dec 31, 20219.9×−3.7
2020Dec 31, 202013.6×+1.3
2019Dec 31, 201912.2×−4.3
2018Dec 31, 201816.5×−26.0
2017Dec 29, 201742.6×+31.6
2016Dec 30, 201611.0×−3.1
2015Dec 31, 201514.1×−13.4
2014Dec 31, 201427.5×−5.1
2013Dec 31, 201332.6×+14.4
2012Dec 31, 201218.2×+3.7
2011Dec 30, 201114.5×–

More Sangamo Therapeutics figures

See a number that looks wrong?